DAC Biotech Overview
- Year Founded
-
2012
- Status
-
Private
- Employees
-
218
- Latest Deal Type
-
2ndary - Private
- Investors
-
19
DAC Biotech General Information
Description
Developer of antibody-drug conjugates designed to treat cancer and other diseases. The company's antibody-drug conjugate technology utilizes proprietary linker and payload platforms for targeted delivery, enabling pharmaceutical companies to develop effective therapies for various diseases.
Contact Information
Website
www.dacbiotech.comCorporate Office
- Number 369 Qiaoxin Road, Qiantang District
- Hangzhou, Zhejiang 900000
- China
Corporate Office
- Number 369 Qiaoxin Road, Qiantang District
- Hangzhou, Zhejiang 900000
- China
DAC Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Secondary Transaction - Private | 27-Jan-2026 | Completed | Generating Revenue | |||
| 10. Later Stage VC | 26-Aug-2021 | Completed | Generating Revenue | |||
| 9. Secondary Transaction - Private | 26-Aug-2021 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series C) | 29-Mar-2021 | Completed | Generating Revenue | |||
| 7. Secondary Transaction - Private | 29-Mar-2021 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 09-Mar-2020 | Completed | Generating Revenue | |||
| 5. Secondary Transaction - Private | 22-Nov-2019 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series B) | 18-Sep-2019 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 28-Aug-2018 | $7.26M | Completed | Generating Revenue | ||
| 2. Early Stage VC (Series A) | 26-May-2017 | $7.26M | $7.26M | Completed | Generating Revenue |
DAC Biotech Comparisons
Industry
Financing
Details
DAC Biotech Competitors (3)
One of DAC Biotech’s 3 competitors is CytomX Therapeutics, a Formerly VC-backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CytomX Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
| BeOne Medicines | Formerly PE-Backed | Beijing, China | ||||
| Ambrx | Formerly PE-Backed | San Diego, CA |
DAC Biotech Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
DAC Biotech Patents
DAC Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025241603-A1 | An antibody drug conjugate with opened rings of thiosuccinimides, its preparation and application thereof | Pending | 24-May-2023 | ||
| WO-2025241452-A1 | An antibody-drug conjugate containing an extra functional compound for enhanced treatment of refractory diseases | Pending | 24-May-2023 | ||
| US-20250339551-A1 | An antibody-drug conjugate having two or more different functional small molecules for enhanced treatment of refractory diseases | Pending | 24-May-2023 | ||
| AU-2024276090-A1 | An antibody-drug conjugate having two or more functional small molecule compounds for enhanced treatment of refractory diseases | Pending | 24-May-2023 | ||
| EP-4642492-A1 | An antibody-drug conjugate having two or more functional small molecule compounds for enhanced treatment of refractory diseases | Pending | 24-May-2023 | A61K47/68037 |
DAC Biotech Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
DAC Biotech Investors (19)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Zhejiang Kunjian Xintai Equity Investment Management | Growth/Expansion | Minority | ||
| CDG Capital | Growth/Expansion | Minority | ||
| CITIC Jingshi Investment | Growth/Expansion | Minority | ||
| CITIC Securities | Investment Bank | Minority | ||
| Citic Securities Investment | Investment Bank | Minority |
DAC Biotech FAQs
-
When was DAC Biotech founded?
DAC Biotech was founded in 2012.
-
Where is DAC Biotech headquartered?
DAC Biotech is headquartered in Hangzhou, China.
-
What is the size of DAC Biotech?
DAC Biotech has 218 total employees.
-
What industry is DAC Biotech in?
DAC Biotech’s primary industry is Drug Discovery.
-
Is DAC Biotech a private or public company?
DAC Biotech is a Private company.
-
What is DAC Biotech’s current revenue?
The current revenue for DAC Biotech is .
-
How much funding has DAC Biotech raised over time?
DAC Biotech has raised $161M.
-
Who are DAC Biotech’s investors?
Zhejiang Kunjian Xintai Equity Investment Management, CDG Capital, CITIC Jingshi Investment, CITIC Securities, and Citic Securities Investment are 5 of 19 investors who have invested in DAC Biotech.
-
Who are DAC Biotech’s competitors?
CytomX Therapeutics, BeOne Medicines, and Ambrx are competitors of DAC Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
